These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 389316)

  • 21. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 22. Framing processes in public commentary on US federal tobacco control regulation.
    Roth AL; Dunsby J; Bero LA
    Soc Stud Sci; 2003 Feb; 33(1):7-44. PubMed ID: 12918520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct-to-consumer prescription drug advertising: history, regulation, and issues.
    Huh J; DeLorme DE; Reid LN; An S
    Minn Med; 2010 Mar; 93(3):50-2. PubMed ID: 20429178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Origins of "Confidential Commercial Information" at the FDA.
    Daval CJR; Kesselheim AS
    JAMA; 2024 Aug; 332(7):533-534. PubMed ID: 39037797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The goose that laid the golden capsule, part I.
    Smith BE
    Tenn Med; 2005 May; 98(5):224-5. PubMed ID: 15934531
    [No Abstract]   [Full Text] [Related]  

  • 26. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

  • 27. Revisiting "the origins of compulsory drug prescriptions".
    Marks HM
    Am J Public Health; 1995 Jan; 85(1):109-15. PubMed ID: 7832245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Forbidden and Permitted Statements about Medications--Loosening the Rules.
    Avorn J; Sarpatwari A; Kesselheim AS
    N Engl J Med; 2015 Sep; 373(10):967-73. PubMed ID: 26332553
    [No Abstract]   [Full Text] [Related]  

  • 29. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
    Tobbell DA
    Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fifty years of the antibiotic industry].
    Telegin LP
    Antibiot Khimioter; 1994 Jan; 39(1):11-2. PubMed ID: 8060190
    [No Abstract]   [Full Text] [Related]  

  • 31. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. James Harvey Young, PhD, (1915-2006). Historian of medical quackery.
    Marcus DM
    Pharos Alpha Omega Alpha Honor Med Soc; 2008; 71(3):16-21. PubMed ID: 18767597
    [No Abstract]   [Full Text] [Related]  

  • 33. Fifty years ago.
    Cooper RM
    Food Drug Law J; 1995; 50 Spec():117-22. PubMed ID: 10343038
    [No Abstract]   [Full Text] [Related]  

  • 34. There really is no controversy.
    Samuels A
    Eur J Clin Nutr; 2009 Aug; 63(8):1044. PubMed ID: 18545263
    [No Abstract]   [Full Text] [Related]  

  • 35. Déjà Vu at the FDA.
    Sharfstein J
    Milbank Q; 2017 Jun; 95(2):245-248. PubMed ID: 28378412
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug industry in France: some historical points].
    Sigvard J
    Bull Acad Natl Med; 1982 Jun; 166(6):829-34. PubMed ID: 6756598
    [No Abstract]   [Full Text] [Related]  

  • 37. James Harvey Young and medical education.
    Turton FE
    Pharos Alpha Omega Alpha Honor Med Soc; 2009; ():58. PubMed ID: 19263656
    [No Abstract]   [Full Text] [Related]  

  • 38. H. Boyd Woodruff (1917-2017).
    Bennett JW; Eveleigh D; Goodman RM
    Science; 2017 Apr; 356(6336):381. PubMed ID: 28450600
    [No Abstract]   [Full Text] [Related]  

  • 39. The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals.
    Greene JA; Watkins ES
    N Engl J Med; 2015 Sep; 373(12):1087-9. PubMed ID: 26287749
    [No Abstract]   [Full Text] [Related]  

  • 40. Shifting terrain in the regulation of off-label promotion of pharmaceuticals.
    Mello MM; Studdert DM; Brennan TA
    N Engl J Med; 2009 Apr; 360(15):1557-66. PubMed ID: 19357413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.